Roswell Park Cancer Institute: Pancreatic Neoplasms trials

The registry lists 13 Pancreatic Neoplasms studies with Roswell Park Cancer Institute as lead sponsor. 1 are open to participants now and 4 have results posted.

Early Phase 1 1Phase 1 7Phase 2 5No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal AdenocarcinomaRecruitingNCT07214298Phase 1/2
• Acceptability of Less Harmful Alternatives to CigarettesCompletedNCT00957424Not applicableResults posted
• Bupropion in Helping Adults Stop SmokingCompletedNCT00534001Phase 2Results posted
• Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic CancerTerminatedNCT00470535Phase 2Results posted
• Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic CancerCompletedNCT00100815Phase 2Results posted
• FL118 for Treating Patients With Advanced Pancreatic Ductal AdenocarcinomaWithdrawnNCT06206876Phase 1
• Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic CancerWithdrawnNCT04870034Early Phase 1
• Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic CancerWithdrawnNCT02575508Phase 1/2
• Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic CancerCompletedNCT02227940Phase 1
• Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic CancerWithdrawnNCT02048943Phase 1
• Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary CancersCompletedNCT01497392Phase 1
• Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine HydrochlorideCompletedNCT00981162Phase 1
• Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By SurgeryWithdrawnNCT00524069Not applicable